FDA Recalls Ipamorelin Acetate Injectable Vials Due to Sterility Concerns
Pharm D Solutions is recalling 11 vials of Ipamorelin Acetate 9 mg/9mL Injectable due to a lack of sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which indicates a reasonable probability of temporary or medically reversible adverse health consequences. The hazard of lack of sterility assurance in an injectable product poses a significant risk of infection, aligning with the 'Severe' criteria for significant injury reports or high-risk contamination.
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a Class II recall for Ipamorelin Acetate 9 mg/9mL Injectable vials. The recall is being conducted by Pharm D Solutions, LLC, located in Houston, Texas. The specific reason for the recall is a lack of sterility assurance.
The affected product consists of 11 vials of Ipamorelin Acetate, which is a prescription-only medication. The recall covers two specific lots: Lot 05022019:50 with an expiration date of 10/29/2019, and Lot 05082019:91 with an expiration date of 06/08/2019. The product was distributed nationwide within the United States.
Consumers and healthcare providers who have this product should stop using it and contact Pharm D Solutions at 1-844-263-6846 for further instructions on how to return or dispose of the medication.
The recalled product
- Product
- Ipamorelin Acetate 9 mg/9mL Injectable vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846
- Manufacturer
- Pharm D Solutions, LLC
- Category
- Drug — Injectable
- Hazard
- Affected units
- 11
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 05022019:50 Exp. 10/29/2019
- 05082019:91 Exp. 06/08/2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 18 recalled by Pharm D Solutions, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · Pharm D Solutions, LLC
See all →- SeverePharm D Solutions Recalls Sermorelin/GHRP-2 &6 Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Sermorelin Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls B-Complex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Testosterone Cypionate Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Human Chorionic Gonadotropin Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SeverePharm D Solutions Recalls Sermorelin/Ipamorelin Powder Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SeverePromise Pharmacy Recalls Ipamorelin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-02-20
- SevereSermorelin Acetate and Ipamorelin Vials Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
- HighIpamorelin and Sermorelin Injectable Medications Recalled Due to Sterility Deviations
FDA (Drugs) · 2022-04-27
- SeverePharmcore Recalls Ipamorelin Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2018-09-05
- SeverePharm D Solutions Recalls Trimix Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07